Powering the patient journey
Combining Clinical Development, Clinical Trial Supply and Early Access Programs, we bring life-changing medicines to patients around the world.
Our vision is to maximize access and generate evidence across the entire clinical development pathway, positively impacting current and future patients.
Powering the patient journey
Combining Clinical Development, Clinical Trial Supply and Early Access Programs, we bring life-changing medicines to patients around the world.
Our vision is to maximize access and generate evidence across the entire clinical development pathway, positively impacting current and future patients.
Powering the patient journey
Combining Clinical Development, Clinical Trial Supply and Early Access Programs, we bring life-changing medicines to patients around the world.
Our vision is to maximize access and generate evidence across the entire clinical development pathway, positively impacting current and future patients.
Our approach
We build long term partnerships with our international pharma and biotech sponsors to deliver a unique service. Our experts work seamlessly across our business units and are there as an extension of your team. We listen carefully to what you tell us and share our insights to enhance results, ensure success and deliver operational excellence.
People & culture
At Bionical Emas, we are one team driven by passion, enthusiasm and a shared purpose, working together to change patients’ lives. We provide you the opportunity to develop a career and while working with an outstanding team that empowers an inclusive future for all. Our shared values establish a unique culture that guides our actions and defines who we are. We strive to provide our people with a welcoming, flexible, and supportive environment. Trust and belonging are paramount, and everyone is invited to be themselves.
Patient advocacy
Patient centricity is fundamental to the work we do at Bionical Emas. We focus on ensuring the patient voice is always represented, creating a positive patient journey and reducing burden where possible when designing Clinical Trials or Early Access Programs.